Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 6:58 p.m.

    📋 Emergent Biosolutions Inc. (EBS) - Financial Results

    Filing Date: 2026-01-14

    Accepted: 2026-01-14 17:13:19

    Event Type: Financial Results

    Event Details:

    Emergent Biosolutions Inc. (EBS) Reports the reporting period Financial Results Emergent Biosolutions Inc. (EBS) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: $775
    • Net Income: $60
    • EPS: Not disclosed
    • Cash and equivalents: $775
      • Targeting a Net Leverage Ratio of 2.0x – 3.0x Adjusted EBITDA going forward 17 1. Excludes potential acquisitions and represents current core business structure Capital Allocation Priorities During 2026

    📊 Key Financial Metrics:

    Metric Value
    Revenue $775
    Net Income $60
    Cash $775

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Emergent Biosolutions Inc.
    • Ticker Symbol: EBS

Search

News categories